Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.

You may be eligible if

• Age 18-65 years. BMI 25-40kg/m3, and CAP more than 290
• Stable weight in the last 3 months prior to enrolling in the study(\<5kg weight variation)
• Imaging showed steatotic liver disease, liver stiffness \<14kPa measured by fibroscan
• Histologically proven NASH/MASH, fibrosis up to F3
• Subjects willing to participate in the study
• Exclusion Criter
• Liver stiffness \>14kPa measured by fibroscan or Fibrosis \>F3
• Diabetes with HbA1c\>8.5%
• Patients with another co-existing active liver disease e.g. hepatitis B or C, alcoholic liver disease
• Patients with cirrhosis, hepatocellular carcinoma(HCC), or other malignancy
• Chronic kidney disease, cardiovascular disorders, uncontrolled hypertension
• Chronic infections, chronic inflammatory diseases
• Patients on weight loss medications e.g semaglutide
• Pregnant or lactating women and those planning a pregnancy A patient who is not willing to participate in the study or failed to provide the consent